A trial of Sustamycin, a sustained-release preparation of tetracycline hydrochloride, in uncomplicated gonorrhoea in sixty males is described, Each patient was given an initial dose of 500 mg. followed by 250 mg. twice daily for 5 days. Of the 57 patients who attended for follow-up 47 (82-5 per cent.) were cured. There were no adverse reactions.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.